Detection of the CHEK2 1100delC mutation by MLPA BRCA1/2 analysis: A worthwhile strategy for its clinical applicability in 1100delC low-frequency populations?

Breast Cancer Research and Treatment

Volumn 107, Issue 3, 2008, Pages 455-457

  Gutiérrez Enríquez, Sara ^a   Balmaña, Judith ^b   Baiget, Montserrat ^a   Díez, Orland ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA FRAGMENT;

BREAST CANCER; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CHEK2 GENE; COLORECTAL CANCER; GENE CLUSTER; GENE FREQUENCY; GENE MUTATION; GENE REARRANGEMENT; GENETIC COUNSELING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GERM LINE; HETEROZYGOTE; HUMAN; LETTER; LUNG CANCER; PREMENOPAUSE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN FOLDING; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; FEMALE; GENE DELETION; GENES, BRCA1; GENES, BRCA2; HUMANS; MUTATION; PROTEIN-SERINE-THREONINE KINASES;

EID: 38649102840     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9555-2     Document Type: Letter

References (13)

1. Martínez-Bouzas C, Beristain E, Guerra I et al (2007) CHEK2 1100delC is present in familial breast cancer cases of the Basque Country. Breast Cancer Res Treat, doi: 10.1007/s10549-006-9351-4
2. Meijers-Heijboer H, van den Ouweland A, Klijn J et al (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31:55-59
3. Weischer M, Bojesen SE, Tybjaerg-Hansen A et al (2007) Increased risk of breast cancer associated with CHEK2*1100delC. J Clin Oncol 25:57-63
4. Vahteristo P, Bartkova J, Eerola H et al (2002) A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 71:432-438
5. Schmidt MK, Tollenaar RA, de Kemp SR et al (2007) Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation. J Clin Oncol 25:64-69
6. Thompson D, Seal S, Schutte M et al (2006) A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers. Cancer Epidemiol Biomarkers Prev 15:2542-2545
7. CHEK2 Breast Cancer Case-Control Consortium (2004) CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am J Hum Genet 74:1175-1182
8. Friedrichsen DM, Malone KE, Doody DR et al (2004) Frequency of CHEK2 mutations in a population based, case-control study of breast cancer in young women. Breast Cancer Res 6:R629-R635
9. Nevanlinna H, Bartek J (2006) The CHEK2 gene and inherited breast cancer susceptibility. Oncogene 25:5912-5919
10. Osorio A, Rodríguez-López R, Diez O et al (2004) The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population. Int J Cancer 108:54-56
11. Bellosillo B, Tusquests I, Longaron R et al (2005) Absence of CHEK2 mutations in Spanish families with hereditary breast cancer. Cancer Genet Cytogenet 161:93-95
12. Sanchez de Abajo A, de la Hoya M, Godino J et al (2005) The CHEK2 1100delC allele is not relevant for risk assessment in HNPCC and HBCC Spanish families. Fam Cancer 4:183-186
13. Gutiérrez-Enríquez S, Díez O, de la Hoya M et al (2007) Screening for large rearrangements of the BRCA2 gene in n Spanish breast/ovarian cancer families. Breast Cancer Res Treat, doi: 10.1007/s10549-006-9376-8